142 related articles for article (PubMed ID: 15113291)
1. Radioresistant laryngeal cancer: beyond the TNM stage.
Nix PA; Greenman J; Cawkwell L; Stafford N
Clin Otolaryngol Allied Sci; 2004 Apr; 29(2):105-14. PubMed ID: 15113291
[TBL] [Abstract][Full Text] [Related]
2. Defining the criteria for radioresistant laryngeal cancer.
Nix PA; Greenman J; Cawkwell L; Stafford ND
Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):705-8. PubMed ID: 15533164
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach.
Almadori G; Bussu F; Cadoni G; Galli J; Paludetti G; Maurizi M
Eur J Cancer; 2005 Mar; 41(5):683-93. PubMed ID: 15763643
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of SCC-Ag, CYFRA 21-1 and selected acute phase proteins in radiotherapy of pharyngeal and laryngeal cancer. A preliminary report.
Kulpa J; Stasik Z; Skołyszewski J; Wójcik E; Rychlik U; Pudełek K
Neoplasma; 2004; 51(2):103-9. PubMed ID: 15190419
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy alone for early-stage squamous cell carcinoma of the larynx and hypopharynx.
Foote RL
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S31-6. PubMed ID: 17848288
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays.
Markowski J; Oczko-Wojciechowska M; Gierek T; Jarzab M; Paluch J; Kowalska M; Wygoda Z; Pfeifer A; Tyszkiewicz T; Jarzab B; Niedzielska I; Borgiel-Marek H
J Physiol Pharmacol; 2009 May; 60 Suppl 1():57-63. PubMed ID: 19609014
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 expression predicts radiotherapy failure in laryngeal cancer.
Nix P; Cawkwell L; Patmore H; Greenman J; Stafford N
Br J Cancer; 2005 Jun; 92(12):2185-9. PubMed ID: 15928664
[TBL] [Abstract][Full Text] [Related]
8. Rationale for adjuvant fatty acid therapy to prevent radiotherapy failure and tumor recurrence during early laryngeal squamous cell carcinoma.
Louw L; Claassen J
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):21-6. PubMed ID: 18054475
[TBL] [Abstract][Full Text] [Related]
9. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Liu WW; Zeng ZY; Wu QL; Hou JH; Chen YY
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):395-400. PubMed ID: 15746850
[TBL] [Abstract][Full Text] [Related]
11. Expression of mucin gene products in laryngeal squamous cancer.
Paleri V; Pearson JP; Bulmer D; Jeannon JP; Wight RG; Wilson JA
Otolaryngol Head Neck Surg; 2004 Jul; 131(1):84-8. PubMed ID: 15243562
[TBL] [Abstract][Full Text] [Related]
12. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
13. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
14. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
15. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
Zhang S; Kong WJ
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma.
Colombo J; Fachel AA; De Freitas Calmon M; Cury PM; Fukuyama EE; Tajara EH; Cordeiro JA; Verjovski-Almeida S; Reis EM; Rahal P
Oncol Rep; 2009 Mar; 21(3):649-63. PubMed ID: 19212623
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
Chang AR; Wu HG; Park CI; Jun YK; Kim CW
Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
[TBL] [Abstract][Full Text] [Related]
18. Assessment of dendritic cell number and radiosensitivity in laryngeal tumours.
Nix P; Stafford N; Cawkwell L; Greenman J
Clin Otolaryngol; 2005 Apr; 30(2):164-8. PubMed ID: 15839869
[TBL] [Abstract][Full Text] [Related]
19. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
Cordes C; Münzel AK; Rudolph P; Hoffmann M; Leuschner I; Gottschlich S
Anticancer Res; 2009 Apr; 29(4):1459-65. PubMed ID: 19414402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
